ArticleBlood advances2021

Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab.

Alessio Bruscaggin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.